Cellular and molecular pathobiology of heart failure with preserved ejection fraction

S Mishra, DA Kass - Nature Reviews Cardiology, 2021 - nature.com
Heart failure with preserved ejection fraction (HFpEF) affects half of all patients with heart
failure worldwide, is increasing in prevalence, confers substantial morbidity and mortality …

Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis

R Pranata, I Huang, AA Lukito… - Postgraduate medical …, 2020 - academic.oup.com
Objectives This systematic review and meta-analysis aimed to assess the association
between N-terminal pro-brain natriuretic peptide (NT-proBNP) and mortality in patients with …

Novel oxidative stress biomarkers with risk prognosis values in heart failure

ML Ng, X Ang, KY Yap, JJ Ng, ECH Goh, BBJ Khoo… - Biomedicines, 2023 - mdpi.com
Oxidative stress (OS) is mediated by reactive oxygen species (ROS), which in
cardiovascular and other disease states, damage DNA, lipids, proteins, other cellular and …

Heart failure with preserved ejection fraction—a concise review

DM Adamczak, MT Oduah, T Kiebalo… - Current cardiology …, 2020 - Springer
Abstract Purpose of Review Heart failure with preserved ejection fraction (HFpEF) is a
relatively new disease entity used in medical terminology; however, both the number of …

Resistin: Potential biomarker and therapeutic target in atherosclerosis

L Zhou, JY Li, PP He, XH Yu, CK Tang - Clinica chimica acta, 2021 - Elsevier
Resistin, a cysteine-rich secretory protein, has a pleiotropic role in humans. Resistin usually
presents as trimer or hexamer in plasma, and targets specific receptors Toll Like Receptor 4 …

Natriuretic peptides in heart failure with preserved left ventricular ejection fraction: from molecular evidences to clinical implications

DM Tanase, S Radu, S Al Shurbaji, GL Baroi… - International journal of …, 2019 - mdpi.com
The incidence of heart failure with preserved ejection fraction (HFpEF) is increasing and its
challenging diagnosis and management combines clinical, imagistic and biological data …

Fibrosis‐4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction

M Nakashima, S Sakuragi, T Miyoshi… - ESC heart …, 2021 - Wiley Online Library
Abstract Aims Fibrosis‐4 index (FIB‐4 index), calculated by age, aspartate
aminotransferase, alanine aminotransferase, and platelet count, is a simple marker to …

Gender-related differences in heart failure biomarkers

G Cediel, P Codina, G Spitaleri, M Domingo… - Frontiers in …, 2021 - frontiersin.org
Important differences in comorbidities and clinical characteristics exist between women and
men with heart failure (HF). In particular, differences in the kinetics of biological circulating …

Biomarkers of HFpEF: natriuretic peptides, high-sensitivity troponins and beyond

P Morfino, A Aimo, V Castiglione, G Vergaro… - Journal of …, 2022 - mdpi.com
Heart failure (HF) is a significant cause of morbidity and mortality worldwide. HF with
preserved ejection fraction (HFpEF) is a complex syndrome, often participated by several …

[HTML][HTML] Biomarkers in heart failure with preserved ejection fraction

A Bayes-Genis, G Cediel, M Domingo… - Cardiac Failure …, 2022 - ncbi.nlm.nih.gov
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous disorder
developing from multiple aetiologies with overlapping pathophysiological mechanisms …